|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61P 37/08 |
| (11) | Patento numeris | 3351560 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18158965.6 |
| Europos patento paraiškos padavimo data | 2009-10-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-04-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 260307 | 2008-10-29 | US |
| (72) |
PAPADOPOULOS, Nicholas J, US
FAIRHURST, Jeanette L, US
HUANG, Tammy T, US
MARTIN, Joel H, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | MEDICAL USE OF HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR |
| MEDICAL USE OF HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR |